Co-founder and Chief Executive Officer
Co-founded Exeliom Biosciences in December 2016.
He is an entrepreneur who developed a wide range of skills in various industries, including investment banking (UBS), venture capital (Pacific Channel), pharmaceutical regulatory affairs (Amgen), biotech operations (Theravectys) and applied research at the Vision Institute in Paris. Benjamin has a master’s degree in Management from the ESSEC Business School following his time at Classes Prépas, as well as a master’s degree in Molecular and Cellular Biology from the Sorbonne University.
Graduated with a Master’s in Management from the French business school HEC. Specialized in entrepreneurship with several experiences working with start-up development in the field of biotechnology. Mathilde also accompanied start-ups in the health sector within the Agoranov incubator prior to joining Exeliom Biosciences in 2018. She is responsible for the day-to-day operational functions of Exeliom Biosciences.
Scientific Project Manager
Biotechnology engineer with a master's degree from the French National School of Biomolecules (ENSTBB).
Pauline has developed an expertise in protein biochemistry, bio-production, molecular biology and animal experimentation, first as an R&D engineer in molecular biology at MedImmune (UK) and then as a research engineer in biotechnology and biology at the MICALIS Institute of INRA.
She is currently leading our preclinical projects.
A team of 20 experienced consultants
covering a wide range of expertises
Oops! Something went wrong while submitting the form.